A detailed history of Norden Group LLC transactions in Organon & Co. stock. As of the latest transaction made, Norden Group LLC holds 32,820 shares of OGN stock, worth $307,851. This represents 0.04% of its overall portfolio holdings.

Number of Shares
32,820
Previous 15,434 112.65%
Holding current value
$307,851
Previous $149 Million 134.61%
% of portfolio
0.04%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 15, 2025

BUY
$8.4 - $10.85 $146,042 - $188,638
17,386 Added 112.65%
32,820 $351 Million
Q2 2025

Jul 15, 2025

SELL
$8.04 - $14.72 $38,551 - $70,582
-4,795 Reduced 23.7%
15,434 $149 Million
Q1 2025

May 07, 2025

SELL
$14.29 - $16.41 $4,729 - $5,431
-331 Reduced 1.61%
20,229 $301 Million
Q4 2024

Feb 05, 2025

BUY
$14.44 - $18.83 $296,886 - $387,144
20,560 New
20,560 $307 Million
Q1 2024

Apr 19, 2024

BUY
$13.78 - $18.8 $260,469 - $355,357
18,902 New
18,902 $355 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $2.39B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Norden Group LLC Portfolio

Follow Norden Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norden Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Norden Group LLC with notifications on news.